Purification of plasmid DNA of pharmaceutical quality
AssigneeGenCell Corporation
InventorsPierre Wils, Monique Ollivier
Life of this patent
Estimating the term…
Abstract
The invention is directed to a process for purifying double-stranded DNA, comprising using ceramic hydroxyapatite column chromatography. The invention is also directed to a purified recombinant plasmid DNA composition, comprising a chromosomal DNA content that is less than or equal to 0.01% as well as to a composition comprising DNA prepared by the foregoing process.
Claims22
In a process for purifying double-stranded DNA comprising lysing cells followed by one or more chromatographic separation steps, the improvement comprising separating the DNA from other biological material in admixture therewith using ceramic hydroxyapatite column chromatography.
A process for purifying double-stranded DNA, comprising
- chemical lysing of cells,
- diafiltration;
- using ceramic hydroxyapatite column chromatography, and
- using affinity chromatography involving triple helix formation between the DNA and an immobilized oligonucleotide.
Dependencies are inferred from the claim text.